Travere Therapeutics, Inc.: Form 8-K, filed Sep 21, 2026
Filed with the SEC on Sep 21, 2026 and accepted by EDGAR at Sep 21, 2026, 16:10 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001438533-26-000068. Last ingested by Listed: Nov 5, 2026, 14:02 ET. Listed shows no prices and gives no investment advice.